(Q41521606)

2 October 2017

Feasibility and efficacy of gemcitabine plus cisplatin combination therapy after curative resection for biliary tract cancer (English)

1 reference

2 October 2017

Osamu Kainuma

1

1 reference

2 October 2017

Fumihiko Miura

2

1 reference

2 October 2017

Daisuke Furukawa

3

1 reference

2 October 2017

Hiroshi Yamamoto

4

1 reference

2 October 2017

Akihiro Cho

5

1 reference

2 October 2017

Keiji Sano

6

1 reference

2 October 2017

Toshio Nakagohri

7

1 reference

2 October 2017

Takehide Asano

8

1 reference

2 October 2017

30 July 2015

1 reference

Journal of Hepato-biliary-Pancreatic Sciences

2 October 2017

1 reference

2 October 2017

22

1 reference

2 October 2017

789-794

1 reference

2 October 2017

11

1 reference

Outcomes in biliary malignancy

2 October 2017

1 reference

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma

21 January 2018

1 reference

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial

21 January 2018

1 reference

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

21 January 2018

1 reference

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

21 January 2018

1 reference

Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)

21 January 2018

1 reference

Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.

21 January 2018

1 reference

Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial

21 January 2018

1 reference

Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors.

21 January 2018

1 reference

Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.

21 January 2018

1 reference

The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.

21 January 2018

1 reference

Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer

21 January 2018

1 reference

Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma

21 January 2018

1 reference

Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JHBP.283

1 reference

2 October 2017

1 reference